Mode
Text Size
Log in / Sign up
N/A N=20 Basic Science

A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin

Skin Disease

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
May 2017
Primary outcome: Primary: Expression Levels of Antimicrobial Peptides in Samples of Normal Appearing Skin and Skin Subjected to Occlusion With and Without Petrolatum. — 9.12; 7.025; 5.415; 8.926 log of copy number

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Petrolatum application under occlusion (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Rockefeller University
Primary completion
Feb 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Expression Levels of Antimicrobial Peptides in Samples of Normal Appearing Skin and Skin Subjected to Occlusion With and Without Petrolatum.
9.12; 7.025; 5.415; 8.926; 6.781; 5.43
PRIMARY
Measurement of Innate Immune Genes (IL6, IL8, and IL1B) in Skin Biopsy Samples With Petrolatum Occlusion, Normal Skin and Occlusion Without Petrolatum to See if There is Any Difference in Expression
10.302; 9.405; 9.100; 8.205; 6.752; 6.034
SECONDARY
Skin Thickness Difference Between Occluded Versus Occluded With Petrolatum Compared With Normal Skin.
41; 32; 24
SECONDARY
T-cell Infiltrate in Occluded Versus Occluded With Petrolatum Compared With Normal Skin.
1.8421; 4.5263; 0.5789

Summary

Petrolatum is a very well-known emollient that has been used since the 1800's. Not only has it been used to help with dry skin, but it is also marketed as a substance that protects minor cuts and burns. In the past it was thought to be inferior to topical antibiotics in infection prevention for cutaneous wounds. However, in 1996 a large, multicenter trial including over 900 patients showed that petrolatum is as safe and effective as the topical antibiotic, bacitracin in preventing infections for patients undergoing dermatological surgery. In this trial, not only did the petrolatum group have similarly low rates of infection, this group also reported no cases of contact dermatitis. Aside from being more expensive than petrolatum, bacitracin and other topical antimicrobials (i.e. neomycin) have been known as common culprits of contact dermatitis. In a study done by the North American Contact Dermatitis Group between 2005-2006, 9.2 and 10% of the over 4,000 patients who were patch tested had an allergic reaction to either bacitracin or neomycin, respectively. For the above reasons, it is clear that petrolatum is an appealing alternative to topical antibiotics for infection prevention in patients undergoing dermatological procedures. This study however lacked any mechanistic analyses to provide molecular insight as to how petrolatum was effective at infection prevention. The aim of this research is to study the effect of petrolatum on innate immune reactions in the skin. In particular, petrolatum's effect on various antimicrobial peptides after contact with the skin for 3 days will be examined. This will be done through immunohistochemistry for various cellular infiltrates as well as mRNA gene expression via RT-PCR analysis for inflammatory and AMP genes. Tissue samples of petrolatum occluded skin will be compared to both healthy skin and skin under occlusion alone as controls. These comparisons will isolate the effect of the petrolatum on the skin.

Eligibility Criteria

Inclusion Criteria

  • Healthy male or female between 18 and 85 years of age
  • Able to give verbal and written informed consent

Exclusion Criteria

  • Subjects taking any of the following systemic or topical therapies (on the back) within 2 weeks of enrollment: corticosteroids, immunosuppressants, and/or any other medications that may affect the outcome of the study
  • subjects with history of keloids
  • subjects with self reported history of hepatitis B or C
  • HIV positive
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02338076). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search